Biologic wound care products are designed to protect the exudate around the wound, and absorb it, which promotes healing. Biologic wound dressings are not sticky, so they won’t stick to your wound and cause further damage. These dressings can be used in conjunction with other products that promote wound healing, including surgery and other invasive procedures. In addition to their wound-healing abilities, biologic wound dressings are also useful for treating acute injuries such as burns.
Get Research Sample PDF with Market Development Insights @ https://www.coherentmarketinsights.com/insight/request-sample/4892
Bioactive bandages are another common use for biologics in wound care. They contain collagen, which provides biologic signals to the wound and serves as a scaffold for the wound to grow on. The right signals will be important for the wound to heal properly. The proper scaffold will encourage the growth of new tissue. By enabling the skin to grow, wounds can become more resistant to infection and other complications. These treatments are designed to work with the body’s unique healing mechanisms.
Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.
For instance, in June 2021, Mallinckrodt Plc. a leading global specialty pharmaceutical company, received the U.S. Food and Drug Administration approval for the ‘StrataGraft’ to treat adult patients with thermal burns which contain intact dermal elements.
Colombia Wound Care Biologics Market – Impact of Coronavirus (Covid-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 258,830,438 cases and 5,174,646 deaths due to Coronavirus (COVID-19) were reported up till November 25, 2021, across the globe.
The COVID-19 pandemic has negatively affected several markets across the globe and is also expected to hamper the demand and supply in Colombia wound care biologics market, owing to limited access to wound management clinics during the COVID-19 outbreak.
Buy Now to Avail Discount @ https://www.coherentmarketinsights.com/promo/buynow/4892
During COVID-19 pandemic, patients have faced limited access to wound care clinics due to stringent lockdown guidelines. Various clinics and healthcare facilities had followed social distancing norms to avoid cross contamination.
Key players involved in the market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the Colombia market. For instance, in August 2018, Organogenesis Inc., a leading regenerative medicine company, and Avista Healthcare Public Acquisition Corp. (AHPAC), a special purpose acquisition company, entered into a definitive merger agreement, under which Organogenesis will become a completely owned subsidiary of AHPAC. Aim of this agreement is to provide integrated healing solutions.
Key Takeaways of the Colombia Wound Care Biologics Market:
- The Colombia wound care biologics market is expected to exhibit a CAGR of 5.4% over the forecast period, owing to rising launches and regulatory approvals of products. For instance, in March 2019, Smith & Nephew plc, a global medical technology company, acquired Osiris Therapeutics, Inc., a fast growing company delivering regenerative medicine products. This acquisition expands market opportunities in high growth regenerative market for Smith & Nephew Plc.
- Among product type, biologic skin substitutes segmentis expected to account for largest market share during the forecast period, owing to rising awareness wound management. For instance, in June 2021, Amniox Medical, Inc. a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue products launched awareness campaign that showcased the Amniox complete portfolio of human birth tissue-based products to ease wound healing and minimize cost associated with care.
- Key players operating in the Colombia wound care biologics market include Smith & Nephew, Plc, Organogenesis, Inc., Integra Life Sciences Corporation, MiMedx Group, Inc., Skye Biologics, Inc., Amino Technology LLC, Osiris Therapeutics, Inc., Alphatec Holdings, Inc. Mallinckrodt Plc., Amniox Medical, Inc., Acelity L.P. Inc., ConvaTec Group Plc, Generex Biotechnology Corporation, and Olaregen Therapeutix Inc.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Epidemiology
- Alternative To Wound Care Biologics
- Regulatory Scenario
- Reimbursement Scenario
- Collaborations and Agreements
- Market Dynamics
- Colombia Wound Care Biologics Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Colombia Wound Care Biologics Market, By Product Type, 2021 – 2028, (US$ Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Biologic Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Enzyme Based Formulations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Growth Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Introduction
- Colombia Wound Care Biologics Market, By Application, 2021 – 2028, (US$ Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Chronic Wounds
- Diabetic Foot Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Venous Leg Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Pressure Ulcer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Diabetic Foot Ulcer
- Acute Wounds
- Surgical Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Burns
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Surgical Wounds
- Introduction
- Colombia Wound Care Biologics Market, By End User, 2021 – 2028, (US$ Mn.)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Introduction
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837